Inter-observer and intra-observer variability in reporting vaginal dose points for cervical cancer in high-dose-rate brachytherapy

PURPOSE: The ICRU 89 recommends reporting a set of vaginal dose points for cervical cancer treatments in order to quantify the goodness of implant. This vaginal dose reporting method for combined external beam radiotherapy and brachytherapy has been adopted by the EMBRACE II study protocol. Large va...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:J Contemp Brachytherapy
Autores principales: Carrasco, Nuria, Chimeno, Jose, Adrià-Mora, Mar, Pérez-Calatayud, María José, Ibáñez, Blanca, Carmona, Vicente, Celada, Francisco, Gimeno, Jose, Lliso, Françoise, Pérez-Calatayud, José
Formato: Artigo
Lenguaje:Inglês
Publicado: Termedia Publishing House 2020
Materias:
Original Paper
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC7207226/
https://ncbi.nlm.nih.gov/pubmed/32395138
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5114/jcb.2020.94494
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares